APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lemborexant Tablets

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Lemborexant Tablets Market Analysis and Forecast 2026-2032

23 December 2025199 pages

Choose your research edition.

Industry ResearchLemborexant Tablets Industry Research Report 2026114 pages · $2,950 USDIndustry Growth & TrendsGlobal Lemborexant Tablets Industry Growth and Trends Forecast to 203279 pages · $3,450 USDMarket StructureGlobal Lemborexant Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lemborexant Tablets Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Lemborexant Tablets Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Lemborexant Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Lemborexant Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Lemborexant Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Lemborexant Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Lemborexant Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Lemborexant Tablets include Eisai. etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Lemborexant Tablets, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Lemborexant Tablets, also provides the sales of main regions and countries. Of the upcoming market potential for Lemborexant Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Lemborexant Tablets sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Lemborexant Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Lemborexant Tablets sales, projected growth trends, production technology, application and end-user industry.

Lemborexant Tablets Segment by Company

Eisai

Lemborexant Tablets Segment by Type

5 mg

2.5mg

10 mg

Lemborexant Tablets Segment by Application

Hospital and Clinic

Retail Pharmacies

Other

Lemborexant Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lemborexant Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lemborexant Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lemborexant Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Lemborexant Tablets in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Lemborexant Tablets manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lemborexant Tablets sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Lemborexant Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 5 mg Major Manufacturers Table 3. 2.5mg Major Manufacturers Table 4. 10 mg Major Manufacturers Table 5. Global Lemborexant Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital and Clinic Major Manufacturers Table 7. Retail Pharmacies Major Manufacturers Table 8. Other Major Manufacturers Table 9. Lemborexant Tablets Industry Trends Table 10. Lemborexant Tablets Industry Drivers Table 11. Lemborexant Tablets Industry Opportunities and Challenges Table 12. Lemborexant Tablets Industry Restraints Table 13. Global Lemborexant Tablets Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Lemborexant Tablets Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Lemborexant Tablets Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Lemborexant Tablets Revenue Market Share by Region (2021-2026) Table 17. Global Lemborexant Tablets Revenue Market Share by Region (2027-2032) Table 18. Global Lemborexant Tablets Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Lemborexant Tablets Sales by Region (2021-2026) & (k units) Table 20. Global Lemborexant Tablets Sales by Region (2027-2032) & (k units) Table 21. Global Lemborexant Tablets Sales Market Share by Region (2021-2026) Table 22. Global Lemborexant Tablets Sales Market Share by Region (2027-2032) Table 23. Global Lemborexant Tablets Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Lemborexant Tablets Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Lemborexant Tablets Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Lemborexant Tablets Sales Market Share by Manufacturers (2021-2026) Table 27. Global Lemborexant Tablets Sales Price (USD/unit) of Manufacturers (2021-2026) Table 28. Global Lemborexant Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Lemborexant Tablets Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Lemborexant Tablets Manufacturers, Product Type & Application Table 31. Global Lemborexant Tablets Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Lemborexant Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Lemborexant Tablets Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Lemborexant Tablets Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Lemborexant Tablets Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Lemborexant Tablets Revenue Market Share by Type (2021-2026) Table 38. Global Lemborexant Tablets Revenue Market Share by Type (2027-2032) Table 39. Global Lemborexant Tablets Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Lemborexant Tablets Sales by Type (2021-2026) & (k units) Table 41. Global Lemborexant Tablets Sales by Type (2027-2032) & (k units) Table 42. Global Lemborexant Tablets Sales Market Share by Type (2021-2026) Table 43. Global Lemborexant Tablets Sales Market Share by Type (2027-2032) Table 44. Global Lemborexant Tablets Price by Type (2021-2026) & (USD/unit) Table 45. Global Lemborexant Tablets Price by Type (2027-2032) & (USD/unit) Table 46. Global Lemborexant Tablets Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Lemborexant Tablets Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Lemborexant Tablets Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Lemborexant Tablets Revenue Market Share by Application (2021-2026) Table 50. Global Lemborexant Tablets Revenue Market Share by Application (2027-2032) Table 51. Global Lemborexant Tablets Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Lemborexant Tablets Sales by Application (2021-2026) & (k units) Table 53. Global Lemborexant Tablets Sales by Application (2027-2032) & (k units) Table 54. Global Lemborexant Tablets Sales Market Share by Application (2021-2026) Table 55. Global Lemborexant Tablets Sales Market Share by Application (2027-2032) Table 56. Global Lemborexant Tablets Price by Application (2021-2026) & (USD/unit) Table 57. Global Lemborexant Tablets Price by Application (2027-2032) & (USD/unit) Table 58. Eisai Company Information Table 59. Eisai Business Overview Table 60. Eisai Lemborexant Tablets Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 61. Eisai Lemborexant Tablets Product Portfolio Table 62. Eisai Recent Development Table 63. North America Lemborexant Tablets Revenue by Type (2021-2026) & (US$ Million) Table 64. North America Lemborexant Tablets Revenue by Type (2027-2032) & (US$ Million) Table 65. North America Lemborexant Tablets Sales by Type (2021-2026) & (k units) Table 66. North America Lemborexant Tablets Sales by Type (2027-2032) & (k units) Table 67. North America Lemborexant Tablets Sales Price by Type (2021-2026) & (USD/unit) Table 68. North America Lemborexant Tablets Sales Price by Type (2027-2032) & (USD/unit) Table 69. North America Lemborexant Tablets Revenue by Application (2021-2026) & (US$ Million) Table 70. North America Lemborexant Tablets Revenue by Application (2027-2032) & (US$ Million) Table 71. North America Lemborexant Tablets Sales by Application (2021-2026) & (k units) Table 72. North America Lemborexant Tablets Sales by Application (2027-2032) & (k units) Table 73. North America Lemborexant Tablets Sales Price by Application (2021-2026) & (USD/unit) Table 74. North America Lemborexant Tablets Sales Price by Application (2027-2032) & (USD/unit) Table 75. North America Lemborexant Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 76. North America Lemborexant Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 77. North America Lemborexant Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 78. North America Lemborexant Tablets Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 79. North America Lemborexant Tablets Sales by Country (2021-2026) & (k units) Table 80. North America Lemborexant Tablets Sales by Country (2027-2032) & (k units) Table 81. North America Lemborexant Tablets Sales Price by Country (2021-2026) & (USD/unit) Table 82. North America Lemborexant Tablets Sales Price by Country (2027-2032) & (USD/unit) Table 83. United States Lemborexant Tablets Revenue (2021-2032) & (US$ Million) Table 84. Canada Lemborexant Tablets Revenue (2021-2032) & (US$ Million) Table 85. Mexico Lemborexant Tablets Revenue (2021-2032) & (US$ Million) Table 86. Europe Lemborexant Tablets Revenue by Type (2021-2026) & (US$ Million) Table 87. Europe Lemborexant Tablets Revenue by Type (2027-2032) & (US$ Million) Table 88. Europe Lemborexant Tablets Sales by Type (2021-2026) & (k units) Table 89. Europe Lemborexant Tablets Sales by Type (2027-2032) & (k units) Table 90. Europe Lemborexant Tablets Sales Price by Type (2021-2026) & (USD/unit) Table 91. Europe Lemborexant Tablets Sales Price by Type (2027-2032) & (USD/unit) Table 92. Europe Lemborexant Tablets Revenue by Application (2021-2026) & (US$ Million) Table 93. Europe Lemborexant Tablets Revenue by Application (2027-2032) & (US$ Million) Table 94. Europe Lemborexant Tablets Sales by Application (2021-2026) & (k units) Table 95. Europe Lemborexant Tablets Sales by Application (2027-2032) & (k units) Table 96. Europe Lemborexant Tablets Sales Price by Application (2021-2026) & (USD/unit) Table 97. Europe Lemborexant Tablets Sales Price by Application (2027-2032) & (USD/unit) Table 98. Europe Lemborexant Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. Europe Lemborexant Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 100. Europe Lemborexant Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 101. Europe Lemborexant Tablets Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 102. Europe Lemborexant Tablets Sales by Country (2021-2026) & (k units) Table 103. Europe Lemborexant Tablets Sales by Country (2027-2032) & (k units) Table 104. Europe Lemborexant Tablets Sales Price by Country (2021-2026) & (USD/unit) Table 105. Europe Lemborexant Tablets Sales Price by Country (2027-2032) & (USD/unit) Table 106. Germany Lemborexant Tablets Revenue (2021-2032) & (US$ Million) Table 107. France Lemborexant Tablets Revenue (2021-2032) & (US$ Million) Table 108. U.K. Lemborexant Tablets Revenue (2021-2032) & (US$ Million) Table 109. Italy Lemborexant Tablets Revenue (2021-2032) & (US$ Million) Table 110. Russia Lemborexant Tablets Revenue (2021-2032) & (US$ Million) Table 111. Spain Lemborexant Tablets Revenue (2021-2032) & (US$ Million) Table 112. Netherlands Lemborexant Tablets Revenue (2021-2032) & (US$ Million) Table 113. Switzerland Lemborexant Tablets Revenue (2021-2032) & (US$ Million) Table 114. Sweden Lemborexant Tablets Revenue (2021-2032) & (US$ Million) Table 115. Poland Lemborexant Tablets Revenue (2021-2032) & (US$ Million) Table 116. China Lemborexant Tablets Revenue by Type (2021-2026) & (US$ Million) Table 117. China Lemborexant Tablets Revenue by Type (2027-2032) & (US$ Million) Table 118. China Lemborexant Tablets Sales by Type (2021-2026) & (k units) Table 119. China Lemborexant Tablets Sales by Type (2027-2032) & (k units) Table 120. China Lemborexant Tablets Sales Price by Type (2021-2026) & (USD/unit) Table 121. China Lemborexant Tablets Sales Price by Type (2027-2032) & (USD/unit) Table 122. China Lemborexant Tablets Revenue by Application (2021-2026) & (US$ Million) Table 123. China Lemborexant Tablets Revenue by Application (2027-2032) & (US$ Million) Table 124. China Lemborexant Tablets Sales by Application (2021-2026) & (k units) Table 125. China Lemborexant Tablets Sales by Application (2027-2032) & (k units) Table 126. China Lemborexant Tablets Sales Price by Application (2021-2026) & (USD/unit) Table 127. China Lemborexant Tablets Sales Price by Application (2027-2032) & (USD/unit) Table 128. Asia Lemborexant Tablets Revenue by Type (2021-2026) & (US$ Million) Table 129. Asia Lemborexant Tablets Revenue by Type (2027-2032) & (US$ Million) Table 130. Asia Lemborexant Tablets Sales by Type (2021-2026) & (k units) Table 131. Asia Lemborexant Tablets Sales by Type (2027-2032) & (k units) Table 132. Asia Lemborexant Tablets Sales Price by Type (2021-2026) & (USD/unit) Table 133. Asia Lemborexant Tablets Sales Price by Type (2027-2032) & (USD/unit) Table 134. Asia Lemborexant Tablets Revenue by Application (2021-2026) & (US$ Million) Table 135. Asia Lemborexant Tablets Revenue by Application (2027-2032) & (US$ Million) Table 136. Asia Lemborexant Tablets Sales by Application (2021-2026) & (k units) Table 137. Asia Lemborexant Tablets Sales by Application (2027-2032) & (k units) Table 138. Asia Lemborexant Tablets Sales Price by Application (2021-2026) & (USD/unit) Table 139. Asia Lemborexant Tablets Sales Price by Application (2027-2032) & (USD/unit) Table 140. Asia Lemborexant Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. Asia Lemborexant Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 142. Asia Lemborexant Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 143. Asia Lemborexant Tablets Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 144. Asia Lemborexant Tablets Sales by Country (2021-2026) & (k units) Table 145. Asia Lemborexant Tablets Sales by Country (2027-2032) & (k units) Table 146. Asia Lemborexant Tablets Sales Price by Country (2021-2026) & (USD/unit) Table 147. Asia Lemborexant Tablets Sales Price by Country (2027-2032) & (USD/unit) Table 148. Japan Lemborexant Tablets Revenue (2021-2032) & (US$ Million) Table 149. South Korea Lemborexant Tablets Revenue (2021-2032) & (US$ Million) Table 150. India Lemborexant Tablets Revenue (2021-2032) & (US$ Million) Table 151. Australia Lemborexant Tablets Revenue (2021-2032) & (US$ Million) Table 152. Taiwan Lemborexant Tablets Revenue (2021-2032) & (US$ Million) Table 153. Southeast Asia Lemborexant Tablets Revenue (2021-2032) & (US$ Million) Table 154. SAMEA Lemborexant Tablets Revenue by Type (2021-2026) & (US$ Million) Table 155. SAMEA Lemborexant Tablets Revenue by Type (2027-2032) & (US$ Million) Table 156. SAMEA Lemborexant Tablets Sales by Type (2021-2026) & (k units) Table 157. SAMEA Lemborexant Tablets Sales by Type (2027-2032) & (k units) Table 158. SAMEA Lemborexant Tablets Sales Price by Type (2021-2026) & (USD/unit) Table 159. SAMEA Lemborexant Tablets Sales Price by Type (2027-2032) & (USD/unit) Table 160. SAMEA Lemborexant Tablets Revenue by Application (2021-2026) & (US$ Million) Table 161. SAMEA Lemborexant Tablets Revenue by Application (2027-2032) & (US$ Million) Table 162. SAMEA Lemborexant Tablets Sales by Application (2021-2026) & (k units) Table 163. SAMEA Lemborexant Tablets Sales by Application (2027-2032) & (k units) Table 164. SAMEA Lemborexant Tablets Sales Price by Application (2021-2026) & (USD/unit) Table 165. SAMEA Lemborexant Tablets Sales Price by Application (2027-2032) & (USD/unit) Table 166. SAMEA Lemborexant Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 167. SAMEA Lemborexant Tablets Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 168. SAMEA Lemborexant Tablets Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 169. SAMEA Lemborexant Tablets Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 170. SAMEA Lemborexant Tablets Sales by Country (2021-2026) & (k units) Table 171. SAMEA Lemborexant Tablets Sales by Country (2027-2032) & (k units) Table 172. SAMEA Lemborexant Tablets Sales Price by Country (2021-2026) & (USD/unit) Table 173. SAMEA Lemborexant Tablets Sales Price by Country (2027-2032) & (USD/unit) Table 174. Brazil Lemborexant Tablets Revenue (2021-2032) & (US$ Million) Table 175. Argentina Lemborexant Tablets Revenue (2021-2032) & (US$ Million) Table 176. Chile Lemborexant Tablets Revenue (2021-2032) & (US$ Million) Table 177. Colombia Lemborexant Tablets Revenue (2021-2032) & (US$ Million) Table 178. Peru Lemborexant Tablets Revenue (2021-2032) & (US$ Million) Table 179. Saudi Arabia Lemborexant Tablets Revenue (2021-2032) & (US$ Million) Table 180. Israel Lemborexant Tablets Revenue (2021-2032) & (US$ Million) Table 181. UAE Lemborexant Tablets Revenue (2021-2032) & (US$ Million) Table 182. Turkey Lemborexant Tablets Revenue (2021-2032) & (US$ Million) Table 183. Iran Lemborexant Tablets Revenue (2021-2032) & (US$ Million) Table 184. Egypt Lemborexant Tablets Revenue (2021-2032) & (US$ Million) Table 185. Key Raw Materials Table 186. Raw Materials Key Suppliers Table 187. Lemborexant Tablets Distributors List Table 188. Lemborexant Tablets Customers List Table 189. Research Programs/Design for This Report Table 190. Authors List of This Report Table 191. Secondary Sources Table 192. Primary Sources List of Figures Figure 1. Lemborexant Tablets Image Figure 2. Global Lemborexant Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lemborexant Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 4. 5 mg Image Figure 5. 2.5mg Image Figure 6. 10 mg Image Figure 7. Global Lemborexant Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Lemborexant Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital and Clinic Image Figure 10. Retail Pharmacies Image Figure 11. Other Image Figure 12. Global Lemborexant Tablets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Lemborexant Tablets Revenue (2021-2032) & (US$ Million) Figure 14. Global Lemborexant Tablets Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Lemborexant Tablets Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Lemborexant Tablets Revenue Market Share by Region (2021-2032) Figure 17. Global Lemborexant Tablets Sales (2021-2032) & (k units) Figure 18. Global Lemborexant Tablets Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Lemborexant Tablets Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Lemborexant Tablets Sales YoY (2021-2032) & (k units) Figure 21. Europe Lemborexant Tablets Sales YoY (2021-2032) & (k units) Figure 22. China Lemborexant Tablets Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Lemborexant Tablets Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Lemborexant Tablets Sales YoY (2021-2032) & (k units) Figure 25. Global Lemborexant Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Lemborexant Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Lemborexant Tablets Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Lemborexant Tablets Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Lemborexant Tablets Revenue Market Share by Type (2021-2032) Figure 31. Global Lemborexant Tablets Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Lemborexant Tablets Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Lemborexant Tablets Sales Market Share by Type (2021-2032) Figure 34. Global Lemborexant Tablets Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Lemborexant Tablets Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Lemborexant Tablets Revenue Market Share by Application (2021-2032) Figure 37. Global Lemborexant Tablets Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Lemborexant Tablets Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Lemborexant Tablets Sales Market Share by Application (2021-2032) Figure 40. North America Lemborexant Tablets Revenue Share by Type (2021-2032) Figure 41. North America Lemborexant Tablets Sales Share by Type (2021-2032) Figure 42. North America Lemborexant Tablets Revenue Share by Application (2021-2032) Figure 43. North America Lemborexant Tablets Sales Share by Application (2021-2032) Figure 44. North America Lemborexant Tablets Revenue Share by Country (2021-2032) Figure 45. North America Lemborexant Tablets Sales Share by Country (2021-2032) Figure 46. Europe Lemborexant Tablets Revenue Share by Type (2021-2032) Figure 47. Europe Lemborexant Tablets Sales Share by Type (2021-2032) Figure 48. Europe Lemborexant Tablets Revenue Share by Application (2021-2032) Figure 49. Europe Lemborexant Tablets Sales Share by Application (2021-2032) Figure 50. Europe Lemborexant Tablets Revenue Share by Country (2021-2032) Figure 51. Europe Lemborexant Tablets Sales Share by Country (2021-2032) Figure 52. China Lemborexant Tablets Revenue Share by Type (2021-2032) Figure 53. China Lemborexant Tablets Sales Share by Type (2021-2032) Figure 54. China Lemborexant Tablets Revenue Share by Application (2021-2032) Figure 55. China Lemborexant Tablets Sales Share by Application (2021-2032) Figure 56. Asia Lemborexant Tablets Revenue Share by Type (2021-2032) Figure 57. Asia Lemborexant Tablets Sales Share by Type (2021-2032) Figure 58. Asia Lemborexant Tablets Revenue Share by Application (2021-2032) Figure 59. Asia Lemborexant Tablets Sales Share by Application (2021-2032) Figure 60. Asia Lemborexant Tablets Revenue Share by Country (2021-2032) Figure 61. Asia Lemborexant Tablets Sales Share by Country (2021-2032) Figure 62. SAMEA Lemborexant Tablets Revenue Share by Type (2021-2032) Figure 63. SAMEA Lemborexant Tablets Sales Share by Type (2021-2032) Figure 64. SAMEA Lemborexant Tablets Revenue Share by Application (2021-2032) Figure 65. SAMEA Lemborexant Tablets Sales Share by Application (2021-2032) Figure 66. SAMEA Lemborexant Tablets Revenue Share by Country (2021-2032) Figure 67. SAMEA Lemborexant Tablets Sales Share by Country (2021-2032) Figure 68. Lemborexant Tablets Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Lemborexant Tablets Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 5 mg
  • 2.5mg
  • 10 mg
Applications
  • Hospital and Clinic
  • Retail Pharmacies
  • Other
Companies covered
  • Eisai

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Lemborexant Tablets Market by Type
  3. 1.2.1 Global Lemborexant Tablets Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 5 mg
  5. 1.2.3 2.5mg
  6. 1.2.4 10 mg
  7. 1.3 Lemborexant Tablets Market by Application
  8. 1.3.1 Global Lemborexant Tablets Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital and Clinic
  10. 1.3.3 Retail Pharmacies
  11. 1.3.4 Other
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Lemborexant Tablets Market Dynamics
  1. 2.1 Lemborexant Tablets Industry Trends
  2. 2.2 Lemborexant Tablets Industry Drivers
  3. 2.3 Lemborexant Tablets Industry Opportunities and Challenges
  4. 2.4 Lemborexant Tablets Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Lemborexant Tablets Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Lemborexant Tablets Revenue by Region
  3. 3.2.1 Global Lemborexant Tablets Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Lemborexant Tablets Revenue by Region (2021-2026)
  5. 3.2.3 Global Lemborexant Tablets Revenue by Region (2027-2032)
  6. 3.2.4 Global Lemborexant Tablets Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Lemborexant Tablets Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Lemborexant Tablets Sales by Region
  9. 3.4.1 Global Lemborexant Tablets Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Lemborexant Tablets Sales by Region (2021-2026)
  11. 3.4.3 Global Lemborexant Tablets Sales by Region (2027-2032)
  12. 3.4.4 Global Lemborexant Tablets Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Lemborexant Tablets Revenue by Manufacturers
  2. 4.1.1 Global Lemborexant Tablets Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Lemborexant Tablets Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Lemborexant Tablets Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Lemborexant Tablets Sales by Manufacturers
  6. 4.2.1 Global Lemborexant Tablets Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Lemborexant Tablets Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Lemborexant Tablets Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Lemborexant Tablets Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Lemborexant Tablets Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Lemborexant Tablets Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Lemborexant Tablets Manufacturers, Product Type & Application
  13. 4.7 Global Lemborexant Tablets Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Lemborexant Tablets Market CR5 and HHI
  16. 4.8.2 2025 Lemborexant Tablets Tier 1, Tier 2, and Tier 3
5 Lemborexant Tablets Market by Type
  1. 5.1 Global Lemborexant Tablets Revenue by Type
  2. 5.1.1 Global Lemborexant Tablets Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Lemborexant Tablets Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Lemborexant Tablets Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Lemborexant Tablets Sales by Type
  6. 5.2.1 Global Lemborexant Tablets Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lemborexant Tablets Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Lemborexant Tablets Sales Market Share by Type (2021-2032)
  9. 5.3 Global Lemborexant Tablets Price by Type
6 Lemborexant Tablets Market by Application
  1. 6.1 Global Lemborexant Tablets Revenue by Application
  2. 6.1.1 Global Lemborexant Tablets Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Lemborexant Tablets Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Lemborexant Tablets Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Lemborexant Tablets Sales by Application
  6. 6.2.1 Global Lemborexant Tablets Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Lemborexant Tablets Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Lemborexant Tablets Sales Market Share by Application (2021-2032)
  9. 6.3 Global Lemborexant Tablets Price by Application
7 Company Profiles
  1. 7.1 Eisai
  2. 7.1.1 Eisai Company Information
  3. 7.1.2 Eisai Business Overview
  4. 7.1.3 Eisai Lemborexant Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Eisai Lemborexant Tablets Product Portfolio
  6. 7.1.5 Eisai Recent Developments
8 North America
  1. 8.1 North America Lemborexant Tablets Market Size by Type
  2. 8.1.1 North America Lemborexant Tablets Revenue by Type (2021-2032)
  3. 8.1.2 North America Lemborexant Tablets Sales by Type (2021-2032)
  4. 8.1.3 North America Lemborexant Tablets Price by Type (2021-2032)
  5. 8.2 North America Lemborexant Tablets Market Size by Application
  6. 8.2.1 North America Lemborexant Tablets Revenue by Application (2021-2032)
  7. 8.2.2 North America Lemborexant Tablets Sales by Application (2021-2032)
  8. 8.2.3 North America Lemborexant Tablets Price by Application (2021-2032)
  9. 8.3 North America Lemborexant Tablets Market Size by Country
  10. 8.3.1 North America Lemborexant Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Lemborexant Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Lemborexant Tablets Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Lemborexant Tablets Market Size by Type
  2. 9.1.1 Europe Lemborexant Tablets Revenue by Type (2021-2032)
  3. 9.1.2 Europe Lemborexant Tablets Sales by Type (2021-2032)
  4. 9.1.3 Europe Lemborexant Tablets Price by Type (2021-2032)
  5. 9.2 Europe Lemborexant Tablets Market Size by Application
  6. 9.2.1 Europe Lemborexant Tablets Revenue by Application (2021-2032)
  7. 9.2.2 Europe Lemborexant Tablets Sales by Application (2021-2032)
  8. 9.2.3 Europe Lemborexant Tablets Price by Application (2021-2032)
  9. 9.3 Europe Lemborexant Tablets Market Size by Country
  10. 9.3.1 Europe Lemborexant Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Lemborexant Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Lemborexant Tablets Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Lemborexant Tablets Market Size by Type
  2. 10.1.1 China Lemborexant Tablets Revenue by Type (2021-2032)
  3. 10.1.2 China Lemborexant Tablets Sales by Type (2021-2032)
  4. 10.1.3 China Lemborexant Tablets Price by Type (2021-2032)
  5. 10.2 China Lemborexant Tablets Market Size by Application
  6. 10.2.1 China Lemborexant Tablets Revenue by Application (2021-2032)
  7. 10.2.2 China Lemborexant Tablets Sales by Application (2021-2032)
  8. 10.2.3 China Lemborexant Tablets Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Lemborexant Tablets Market Size by Type
  2. 11.1.1 Asia Lemborexant Tablets Revenue by Type (2021-2032)
  3. 11.1.2 Asia Lemborexant Tablets Sales by Type (2021-2032)
  4. 11.1.3 Asia Lemborexant Tablets Price by Type (2021-2032)
  5. 11.2 Asia Lemborexant Tablets Market Size by Application
  6. 11.2.1 Asia Lemborexant Tablets Revenue by Application (2021-2032)
  7. 11.2.2 Asia Lemborexant Tablets Sales by Application (2021-2032)
  8. 11.2.3 Asia Lemborexant Tablets Price by Application (2021-2032)
  9. 11.3 Asia Lemborexant Tablets Market Size by Country
  10. 11.3.1 Asia Lemborexant Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Lemborexant Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Lemborexant Tablets Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Lemborexant Tablets Market Size by Type
  2. 12.1.1 SAMEA Lemborexant Tablets Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Lemborexant Tablets Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Lemborexant Tablets Price by Type (2021-2032)
  5. 12.2 SAMEA Lemborexant Tablets Market Size by Application
  6. 12.2.1 SAMEA Lemborexant Tablets Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Lemborexant Tablets Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Lemborexant Tablets Price by Application (2021-2032)
  9. 12.3 SAMEA Lemborexant Tablets Market Size by Country
  10. 12.3.1 SAMEA Lemborexant Tablets Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Lemborexant Tablets Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Lemborexant Tablets Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Lemborexant Tablets Value Chain Analysis
  2. 13.1.1 Lemborexant Tablets Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Lemborexant Tablets Production Mode & Process
  6. 13.2 Lemborexant Tablets Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Lemborexant Tablets Distributors
  9. 13.2.3 Lemborexant Tablets Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst